WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Lucas Delmonico
PeerJ Reviewer
35 Points

Contributions by role

Reviewer 35

Contributions by subject area

Bioinformatics
Molecular Biology
Gastroenterology and Hepatology
Oncology
Medical Genetics

Lucas Delmonico

PeerJ Reviewer

Summary

Graduated in B.Sc (Federal University of Goiás - UFG) and with master's and doctorate in Medical Sciences (Rio de Janeiro State University - UERJ). One-year internship at Bioarray (Farmington, CT, USA), working with circulating tumor cells (CTCs) and microarrays. Lucas has experience in the field of Molecular Pathology in impalpable breast lesions and myelodysplastic syndromes. He is a member of the Chronic-Degenerative Diseases research group, registered at CNPQ (National Council for Scientific and Technological Development- Brazil). He mainly works in the following subjects: investigation and validation of genetic tests, circulating DNA and liquid biopsy of patients with initial breast cancer; and has been looking for innovations in health, especially in the area of clinical research and innovations in clinical diagnosis.

Bioinformatics Biophysics Biotechnology Computational Biology Genetics

Past or current institution affiliations

Universidade Federal do Rio de Janeiro

Websites

  • LinkedIn

PeerJ Contributions

  • Reviewed 1

Signed reviews submitted for articles published in PeerJ Note that some articles may not have the review itself made public unless authors have made them open as well.

April 16, 2021
TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
Jia Li, Zhaoyan Li, Yajie Ding, Yan Xu, Xiaohong Zhu, Nida Cao, Chen Huang, Mengmeng Qin, Feng Liu, Aiguang Zhao
https://doi.org/10.7717/peerj.11146 PubMed 33959414